Ownership
Private
Stage
Other
Preclinical
Phase 1
Phase 2
Phase 3
Approved
Modalities
Gene therapyCell therapyOligonucleotide therapeuticsRNA and DNA editing therapiesSmall moleculeAntibodyAntibody-drug conjugate

Pathway Bioventures General Information

Pathway Bioventures is a seed-stage venture capital fund investing in early-stage life sciences companies developing next-generation precision therapeutics for unmet medical needs. They focus on genetic medicine and targeted therapies for molecularly defined patient populations.

Contact Information

Primary Industry
Investors
Corporate Office
Chicago, Illinois
USA

Drug Pipeline

No pipeline data available

For full access to Pathway Bioventures's pipeline data

Book a demo

Key Partnerships

Co-invests with top biotech VCs and pharma corporate venture arms

Need more data on over 80,000 life science companies, including over 1200 biotechs?

Book a demo

Pathway Bioventures Funding

No funding data available

Early Stage VC (Series A)04-Jun-2020$38MCompletedPhase 1
Seed Round12-Feb-2019$8.5MCompletedStartup

Interested in comprehensive profile data?

We'll help you find what you need

Learn more
To view Pathway Bioventures's complete valuation and funding history, request access »

Pathway Bioventures Financial Metrics